[1]
A. Garcia-Zamalloa, M. B. Basauri, M. G. Urcelay, and A. Sanz, “Dasatinib-induced chylothorax beyond 5 years of treatment: is there actually any limit?”, EJCRIM, vol. 10, no. 7, Jun. 2023, doi: 10.12890/2023_003921.